Comparision of injection nalbuphine as an adjuvant to injection bupivacaine for pain during post operative period

Not yet recruiting

• Conditions: Medical and Surgical,

• Registration Number: CTRI/2023/06/053700
• Lead Sponsor: Datta Meghe Institute of Higher Education and Research

Brief Summary

**The aim of the study is to compare the efficacy of the addition of intrathecal injection nalbuphine as an adjucant Bupivacaine with intrathecal injection Bupivacaine alone for analgesia in endoscopic urological studies.**

Detailed Description

Not available

Study Timeline

• Study Start: 2023-06-18
• Last Update Posted: 2023-07-06

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients undergoing urological surgeries,duration 1-3 hours.ASA I and II, MPC I and II.

Exclusion Criteria

Lack of valid consent,ASA grade III and IV, patient with neurological disorder,bleeding disorder,patients on anticoagulants,infection at block site.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The addition of adjuvant 1.5 mg Nalbuphine prolongs the duration of post operative analgesia	post operative 24 hours

Secondary Outcome Measures

Name	Time	Method
Compare effects on Hemodynamic parameters,onset and suration of sensory and motor block,side effects if any	2 hours post operative

Trial Locations

Locations (1)

Jawaharlal Nehru Medical College; 🇮🇳 Wardha, MAHARASHTRA, India

Jawaharlal Nehru Medical College

🇮🇳Wardha, MAHARASHTRA, India

Saiesh Raut Dessai

Principal investigator

8390716609

saieshrautdessai4321@gmail.com